Compare PROF & MRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PROF | MRBK |
|---|---|---|
| Founded | N/A | 2004 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 247.5M | 235.5M |
| IPO Year | 2017 | 2018 |
| Metric | PROF | MRBK |
|---|---|---|
| Price | $6.80 | $20.63 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $12.00 | ★ $20.75 |
| AVG Volume (30 Days) | 75.8K | ★ 149.5K |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 3.05% |
| EPS Growth | 25.89 | ★ 30.34 |
| EPS | ★ 0.19 | 0.17 |
| Revenue | ★ $16,098,000.00 | $6,316,000.00 |
| Revenue This Year | $92.40 | $25.40 |
| Revenue Next Year | $64.10 | $8.15 |
| P/E Ratio | ★ $36.63 | $119.00 |
| Revenue Growth | ★ 50.73 | 10.13 |
| 52 Week Low | $3.92 | $13.81 |
| 52 Week High | $8.95 | $21.59 |
| Indicator | PROF | MRBK |
|---|---|---|
| Relative Strength Index (RSI) | 47.19 | 68.81 |
| Support Level | $6.43 | $18.42 |
| Resistance Level | $7.06 | $20.72 |
| Average True Range (ATR) | 0.38 | 0.65 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 31.75 | 95.30 |
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
Meridian Corp is a bank holding company based in the United States. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal and business lending and deposit services. It operates in three reportable segments, including Bank, Wealth, and Mortgage. Meridian generates maximum revenue from the Bank segment, which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans. Geographically, it operates in Pennsylvania, New Jersey, and Delaware, as well as in the Central Maryland market and southwest Florida, U.S.